TELA Bio (TELA) EBIAT (2018 - 2025)
TELA Bio (TELA) has 8 years of EBIAT data on record, last reported at -$8.6 million in Q3 2025.
- For Q3 2025, EBIAT rose 17.06% year-over-year to -$8.6 million; the TTM value through Sep 2025 reached -$39.0 million, up 6.08%, while the annual FY2024 figure was -$37.8 million, 18.91% up from the prior year.
- EBIAT reached -$8.6 million in Q3 2025 per TELA's latest filing, up from -$9.9 million in the prior quarter.
- Across five years, EBIAT topped out at -$5.7 million in Q1 2024 and bottomed at -$12.9 million in Q4 2023.
- Average EBIAT over 5 years is -$10.1 million, with a median of -$10.5 million recorded in 2022.
- Peak YoY movement for EBIAT: soared 52.93% in 2024, then tumbled 98.98% in 2025.
- A 5-year view of EBIAT shows it stood at -$8.6 million in 2021, then dropped by 23.75% to -$10.6 million in 2022, then dropped by 21.45% to -$12.9 million in 2023, then rose by 28.56% to -$9.2 million in 2024, then increased by 6.57% to -$8.6 million in 2025.
- Per Business Quant database, its latest 3 readings for EBIAT were -$8.6 million in Q3 2025, -$9.9 million in Q2 2025, and -$11.3 million in Q1 2025.